PDA

pharmaceutical preparations for hormone replacement therapies, namely cancer gene therapy, diabetes therapy, T-Cell therapy, blood growth factors, neural growth factor therapy, anti-coagulant therapy, biological response modifier therapy, anti-cancer antibody therapy, anti-viral therapy, anti-microbial therapy; drug screening reagents, namely cytokine receptor assay reagents; and high throughput assays